Cargando…
Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
BACKGROUND: Recent attention has focused on understanding the role of the brain-renin-angiotensin-system (RAS) in stroke and neurodegenerative diseases. Direct evidence of a role for the brain-RAS in Parkinson's disease (PD) comes from studies demonstrating the neuroprotective effect of RAS inh...
Autores principales: | Grammatopoulos, Tom N, Jones, Susan M, Ahmadi, Ferogh A, Hoover, Brian R, Snell, Lawrence D, Skoch, Jesse, Jhaveri, Vimal V, Poczobutt, Andy M, Weyhenmeyer, James A, Zawada, W Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1783655/ https://www.ncbi.nlm.nih.gov/pubmed/17224059 http://dx.doi.org/10.1186/1750-1326-2-1 |
Ejemplares similares
-
Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
por: Goloborshcheva, Valeria V., et al.
Publicado: (2022) -
Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity
por: Wang, Yingqing, et al.
Publicado: (2019) -
Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice
por: Smeyne, Richard Jay, et al.
Publicado: (2016) -
Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model
por: Lu, Yi, et al.
Publicado: (2018) -
Activity-dependent regulation of NMDA receptors in substantia nigra dopaminergic neurones
por: Wild, Angela R, et al.
Publicado: (2014)